登録して招待リンクを共有すると、動画再生報酬と紹介報酬を獲得できます。

IPO Newsroom
@IPONewsroom_
Your IPO newsroom. S-1 filings, pricing updates, debut coverage, and post-IPO performance.
参加 November 2024
109 フォロー中    32K ファン
Samsung Biologics' $2 billion rights offering was oversubscribed more than five times, drawing bids for 11.9 million shares against 2.3 million offered. The proceeds help fund its acquisition of PolyPeptide, per Dow Jones.
もっと見る